Oklahoma Cardiovascular & Hypertension — Oklahoma City, Oklahoma

Oklahoma Cardiovascular & Hypertension is a clinical research site located in Oklahoma City, Oklahoma, United States 73132.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Oklahoma Cardiovascular & Hypertension has participated in 2 clinical trials.

Therapeutic areas: Hypertension, Angina Pectoris.

Sponsors: Novartis Pharmaceuticals, Tasly Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oklahoma Cardiovascular & Hypertension?

Oklahoma Cardiovascular & Hypertension has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oklahoma Cardiovascular & Hypertension conducted?

Oklahoma Cardiovascular & Hypertension has 2 clinical trials on record. Their work covers Hypertension, Angina Pectoris.

Is Oklahoma Cardiovascular & Hypertension accredited by Crixeo Health?

Oklahoma Cardiovascular & Hypertension has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oklahoma Cardiovascular & Hypertension?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.